FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge...

Published on 25 Nov 2024 on Benzinga · via Yahoo Finance

On Friday, the FDA approved BridgeBio Pharma, Inc.’s (NASDAQ:BBIO) Attruby (acoramidis), an...

Read the rest of the article

Start tracking your investments with Statfolio

On Friday, the FDA approved BridgeBio Pharma, Inc.’s (NASDAQ:BBIO) Attruby (acoramidis), an...

Benzinga · via Yahoo Finance 25 Nov 2024

Each year, I offer a few January bounce candidates ones that I also think may sustain gains durin...

Investing.com 25 Nov 2024

For Immediate Release Chicago, IL – November 21, 2024 – Zacks.com announces the list of Stocks...

Zacks · via Yahoo Finance 21 Nov 2024

Year to date, the three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — hav...

Zacks · via Yahoo Finance 20 Nov 2024

For many investors, the main point of stock picking is to generate higher returns than the overal...

Simply Wall St. · via Yahoo Finance 19 Nov 2024

Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment...

Zacks · via Yahoo Finance 19 Nov 2024

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 18 Nov 2024

We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this...

Insider Monkey · via Yahoo Finance 18 Nov 2024

(Bloomberg) -- Stocks fell on Friday, closing out the worst week in more than two months, as Trum...

Bloomberg · via Yahoo Finance 15 Nov 2024

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...

Zacks · via Yahoo Finance 15 Nov 2024